
Novo Nordisk Taiwan: Transforming the Future of Obesity Care
Novo Nordisk Taiwan is transforming the way obesity is understood and treated, pushing beyond weight loss to position it as a chronic disease that demands urgent, long-term care. With cutting-edge research, public health partnerships, and advocacy to fight stigma, the company is driving a systemic shift in how Taiwan addresses one of its most pressing health challenges.